Savara Inc. ( SVRA) - Stock Earnings
SVRA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
SVRA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -32.2 million USD | — USD |
| 2026Q1 | -37.3 million USD | — USD |
| 2026Q2 | -40.2 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
SVRA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -54.7 million USD | — USD |
| 2024 | -95.9 million USD | — USD |
| 2025 | -118.8 million USD | — USD |
| 2026 Est. | — | — |
SVRA
Price: $5.38
52 week price:
Earnings Per Share: -0.54 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 765007
Ebitda: -6.6 millionMarket Capitalization: 1.1 billion